Showing results (151-160 of 283) with videos related to

Sort By:
Pageof 29
Schizophrenia Bulletin|July 8, 2000
Schizophrenia research: a progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia ResearchP F Buckley, R W Buchanan, C A Tamminga, et al.
Neuroreport|April 19, 1995
Ketamine activates psychosis and alters limbic blood flow in schizophreniaA C Lahti, H H Holcomb, D R Medoff, et al.
Peptides|July 1, 1985
Cholecystokinin octapeptide analogues stable to brain proteolysisM Knight, P Barone, C A Tamminga, et al.
Experimental Neurology|August 1, 1997
The effect of chronic haloperidol treatment on dendritic spines in the rat striatumJ J Kelley, X M Gao, C A Tamminga, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2000
Ketamine effects on eye movementsM A Weiler, G K Thaker, A C Lahti, et al.
Clinical Neuropharmacology|January 1, 1985
Caerulein treatment of Parkinson's diseaseG Bruno, S Ruggieri, T N Chase, et al.
Schizophrenia Bulletin|December 16, 1998
Schizophrenia research: a biennium of progress. Proceedings from the Sixth International Congress on Schizophrenia Research. Colorado Springs, CO, April 12-16, 1997R W Buchanan, P F Buckley, C A Tamminga, et al.
Archives of General Psychiatry|May 1, 1996
Catching up on schizophrenia. The Fifth International Congress on Schizophrenia Research, Warm Springs, Va, April 8-12, 1995P F Buckley, R W Buchanan, S C Schulz, et al.
International Clinical Psychopharmacology|September 1, 1995
Glutamate pharmacology and the treatment of schizophrenia: current status and future directionsC A Tamminga, H H Holcomb, X M Gao, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2000
Assessing the efficacy of treatments for the deficit syndrome of schizophreniaB Kirkpatrick, A Kopelowicz, R W Buchanan, et al.
Pageof 29